SEC Form 4 · accession 0001445064-15-000151
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew K Harbaugh
Officer — Sr. VP & CFO
Period of report
Dec 1, 2015
Accepted (ET)
Dec 2, 2015 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 1, 2015 | F | 1,009 | $71.48 | D | 46,190 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 206 shares acquired between June 4, 2015 and November 9, 2015, under the Mallinckrodt employee stock purchase plan.